<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2013</study_start_year><condition>Post-operative infective complications and long term oncological outcome in patients undergoing surgery for colorectal cancer</condition><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><condition>Postoperative infection</condition><disease>Colorectal Cancer</disease><disease>Postoperative Infection</disease><disease>Colorectal Neoplasms</disease><disease>Post-operative Infective Complications And Long Term Oncological Outcome In Patients Undergoing Surgery For Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2136190</full_dataset_link><location>Netherlands</location><study_start_month>1</study_start_month><keyword>SDD</keyword><keyword>Liposomal amphotericin B</keyword><keyword>Anastomotic leakage</keyword><keyword>Colistin</keyword><keyword>Amphotericin B</keyword><keyword>Tobramycin</keyword><keyword>Selective decontamination of the digestive tract</keyword><repository>ECRIN MDR</repository><study_status>Terminated</study_status></additional><is_claimable>false</is_claimable><name>Does Administration of Antibiotics in Patients Undergoing Surgery for Colorectal Cancer Result in Less Complications and Better Prognosis?</name><description>The primary objectives of this randomized clinical trial are to evaluate if perioperative SDD can reduce clinical anastomotic leakage rate and its septic consequences as well as other infectious complications. By reduction of septic complications long-term oncological outcome might simultaneously improve.</description><dates><creation>2013-01-15</creation></dates><accession>2136190</accession><cross_references><ClinicalTrials___gov>NCT01740947</ClinicalTrials___gov><EU Clinical Trials Register>2011-002211-28</EU Clinical Trials Register></cross_references></HashMap>